Related Experiment Video
Updated: Apr 26, 2026

07:41
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
2.3K
Complex metastatic niches: already a target for therapy?
Paloma Ordóñez-Morán1, Joerg Huelsken1
1École Polytechnique Fédérale de Lausanne (EPFL), ISREC (Swiss Institute for Experimental Cancer Research), Lausanne, Switzerland.
Current Opinion in Cell Biology
|July 19, 2014
Summary
Cancer cells create supportive microenvironments for metastasis, leading to immune suppression. Targeting these dynamic tumor niches presents therapeutic challenges and opportunities.
Area of Science:
- Oncology
- Cancer Biology
- Tumor Microenvironment
Background:
- Metastasis is an inefficient process requiring supportive microenvironments for cancer cell survival and immune evasion.
- These tumor-induced niches are distinct from the primary site, exhibiting unique molecular and functional characteristics.
- Inadequate niche support can lead to tumor dormancy.
Purpose of the Study:
- To explore the complex interactions between cancer cells and their microenvironment during metastatic spread.
- To discuss the induction of tumor-supportive and immune-suppressive niches.
- To examine tissue-specific differences in these dynamic niches.
Main Methods:
- Review of current understanding of metastatic niche formation.
- Analysis of factors inducing supportive and immune-suppressive microenvironments.
- Discussion of co-evolutionary dynamics between cancer cells and stromal components.
Main Results:
- Metastatic niches are actively generated and distinct from primary tumor sites.
- These niches facilitate cancer cell survival, proliferation, and immune escape.
- Tumor dormancy can occur if the microenvironment is not sufficiently supportive.
Conclusions:
- Understanding the complexity of dynamic metastatic niches is crucial.
- Targeting stromal responses within these niches offers potential for cancer diagnosis and therapy.
- Significant challenges remain in therapeutically exploiting these interactions.
Related Concept Videos
Metastasis
5.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K
Targeted Cancer Therapies
7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.0K
The Tumor Microenvironment
6.3K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.3K
Mitogens and the Cell Cycle
6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K

